Detalhe da pesquisa
1.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Lancet
; 399(10321): 237-248, 2022 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34953526
2.
Real time and accelerated stability studies of Tetanus toxoid manufactured in public sector facilities of Pakistan.
Pak J Pharm Sci
; 26(6): 1271-8, 2013 11.
Artigo
Inglês
| MEDLINE | ID: mdl-24191338